BioSpace News Archive

Presentations on bio-layer interferometry for improved formulation screening and use of new excipients to prevent particle formation

Squarex, a clinical-stage pharmaceutical company developing a topical immunomodulator for the long-term prevention of recurrent cold sores and other infections caused by herpes simplex viruses, today announced positive results from a Phase 2 study of its investigational compound SQX770

Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and continuous treatment with long-lasting effect.

IceCure Medical Ltd. (TASE: ICCM), an Israeli medical device company that has developed a minimally-invasive cryoablation technology to treat malignant and benign tumors by freezing without the need for surgery, has received Israeli AMAR authorization for use of its freezing technology in specific indications.

CVS Pharmacy, announced that, customers will be able to enroll in CarePass at participating CVS Pharmacy locations nationwide, or online at CVS.com/carepass.

Speeding the path to disease understanding through improved ease-of-use and faster results

Aprea Therapeutics, a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, today announced the appointment of Scott Coiante as Senior Vice President and Chief Financial Officer.

Boehringer Ingelheim today announced updated, interim analysis results from the GioTag study, showing that initiating treatment with afatinib followed by osimertinib provided an overall survival (OS) of almost four years (45.7 months) in patients with Del19-positive tumors

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced it has signed a long-term lease agreement with Bristol-Myers Squibb Company (NYSE: BMY)

A new and innovative Transitional Care program has been implemented in Richton, Mississippi thanks to a collaboration between Perry County General Hospital and Allevant Solutions, a joint venture between Mayo Clinic and Select Medical.